HilleVax Inc.

NASDAQ: HLVX · Real-Time Price · USD
2.07
-0.01 (-0.48%)
At close: Aug 15, 2025, 3:48 PM

HilleVax Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 2.16M 2.25M 3K
Gross Profit
n/a -2.16M -2.25M -3K
Operating Income
-155.29M -133.34M -65.11M -53.43M
Interest Income
7.05M 9.71M 3.88M 2.84K
Pretax Income
-147.27M -123.57M -159.81M -102.41M
Net Income
-147.27M -123.57M -257M -85.03M
Selling & General & Admin
28.79M 26.66M 16.7M 5.76M
Research & Development
78.17M 106.68M 45.91M 10.01M
Other Expenses
48.33M n/a -94.7M n/a
Operating Expenses
155.29M 133.34M 62.61M 15.77M
Interest Expense
-3.32M 2.39M 3.41M 2.84M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 133.34M 62.61M 15.77M
Income Tax Expense
n/a n/a 97.2M -17.38M
Shares Outstanding (Basic)
49.15M 40.6M 37.66M 30.19M
Shares Outstanding (Diluted)
49.15M 40.6M 37.66M 30.19M
EPS (Basic)
-3 -3.04 -6.83 -2.82
EPS (Diluted)
-3 -3.04 -6.83 -2.82
EBITDA
-155.29M -132.47M -65.11M -99.56M
EBIT
-150.59M -133.34M -62.61M -99.56M
Depreciation & Amortization
n/a 879K 2.25M 3K